Discover the most read content on Bizcommunity's Healthcare site over the past year below...
18 Dec 2018
Feeling a bit state-capsized, swept along by more waves than a cryptocurrency chart? Here are some life-saving festive content ideas...
Bizcommunity.com 15 Oct 2018
South Africans need to better understand the potential risks associated with using medication to combat pain, as even the use of certain pain medications, could lead to an individual needing professional help for addiction to opioids...
Cipla 5 Jul 2018
The 2017 cold and flu season is almost upon us again... Insight Survey's latest SA Cold and Flu Industry Landscape Report 2017 carefully unfolds the local cold and flu remedy markets...
Insight Survey 13 Mar 2017
Manufacturers of brand name drugs will not be able to take advantage of the Department of Health's recently announced 7.5% drug price increase for this year, due to cutthroat generic competition that is driving South African drug costs down...
17 Feb 2015
The introduction of several new generic intravenous (IV) therapies in South Africa could keep spiralling healthcare costs in check...
17 Nov 2014
Ask your pharmacist for advice on self-medication to help you make smart health choices.
22 Jul 2014
At an adjudication by the Marketing Code Authority (MCA), which regulates the local pharmaceutical industry, both Roche and Novartis distanced themselves from the recent statement on intellectual property rights by the Swiss Chamber of Commerce, SwissCham Southern Africa.
18 Mar 2014
This week it was confirmed that Kaizer Chiefs player, Josta Dladla, tested positive for the banned stimulant, methylhexanamine, commonly known as 1.3-dimethyl or DMAA, the use of which is banned in professional sport.
17 Jan 2014
It is important for South African consumers to make sure that the pharmaceutical products they purchase are manufactured safely and comply with the necessary standards, as taking unsafe, illegal medicines can have dangerous consequences.
Manfred Boensch 11 Oct 2013
One of South Africa's most popular contraceptives, Yasmin, is the subject of a bitter court battle that pits a generic drugs company against a multinational.
10 Oct 2013
The National Association of Pharmaceutical Manufacturers (NAPM) believes that a switch of 5% of the volume of branded medicines to a generic equivalent could save the healthcare industry and patients in excess of R400-million per year.
26 Sep 2013